Effects of intraperitoneal administration of OK-432 for patients with advanced cancer
Tetsuya Toge(Hiroshima University), Takao Hattori(Hiroshima University), Kiyoshi Aratani(Hiroshima University), K Hisamatsu(Hiroshima University), Akira Kameda(Hiroshima University), Hirofumi Yamada(Hiroshima University), Katsumasa Kuroi
Cited by 12
Related Papers
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2017|122
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111